Skip to main content
. 2002 Sep;184(18):5011–5017. doi: 10.1128/JB.184.18.5011-5017.2002

TABLE 1.

Origin of strains, MICs, and hydrolytic ability

Strain designation Origin MIC (mg liter−1)f Degradation (%)g
E. cloacae
    EMa Mineral supplement >3,200 99.9
    ID 67037b Clinical strain 3,200 12.7
    ID 67284b Clinical strain 3,200 12.8
    LSPQ 3022 Reference strain 3,200 15.3
    LSPQ 3345 Reference strain 3,200 19.2
E. gergoviae
    G1c Eye liner >3,200 100
    G2c Foundation 3,200 10.3
    G3c Exfoliating gel 3,200 8.9
    G4c Foundation 3,200 8.5
    G5c Clinical strain 3,200 7.8
    G6c Cream 3,200 10.4
    G7c Challenge test 3,200 14.7
    G8c Shampoo 3,200 14.4
    G9c Cream 3,200 11.4
    G10c Shampoo 3,200 12.3
    G11c Cream 3,200 16.3
    G12c Rinsing material 3,200 97.9
    G13c Clinical strain 1,600 15.5
    G14c Clinical strain 3,200 20.0
    G15c Clinical strain 3,200 22.6
    GMa Mineral supplement 3,200 18.7
    WLd Syrup 3,200 14.8
    LSPQ 3347 Reference strain 3,200 14.0
    ATCC 33028 Reference strain 3,200 12.6
    ATCC 33426 Reference strain 3,200 14.7
    ATCC 33428 Reference strain 3,200 18.1
E. aerogenes
    AE1c Clinical strain 3,200 15.4
    AE1c Clinical strain 3,200 12.7
    AE1c Clinical strain 3,200 14.7
    LSPQ 3811 Reference strain 3,200 15.6
    ATCC 13048 Reference strain 3,200 12.9
P. agglomerans
    ID 60635b Clinical strain 3,200 10.1
    ID 65518b Clinical strain 3,200 14.4
    LSPQ 3353 Reference strain 1,600 14.5
    LSPQ 3825 Reference strain 800 13.5
E. coli
    ID 41839e Clinical strain 3,200 9.1
    ATCC 25922 Reference strain 1,600 12.6
    ATCC 35218 Reference strain 3,200 11.3
B. cepacia IFO 15124 Oil-in-water emulsion 1,600 37.9
P. aeruginosa
    ID 33122e Clinical strain 3,200 12.4
    ATCC 33350 Reference strain 1,600 10.2
a

Provided by a private company in Quebec, Canada.

b

Provided by the “Laboratoire de Santé Publique” (LSPQ), Quebec, Canada.

c

Provided by C. Bollet, Faculty of Medicine, INSERM, Marseille, France.

d

Provided by a private company in Ontario, Canada.

e

Provided by the Maisonneuve-Rosemont Hospital, Montreal, Canada.

f

Expressed as the concentration of methyl paraben.

g

Expressed as the percentage of 800 ppm (5.7 mM) of methyl paraben degraded after 2 h of incubation by an exponentially growing culture.